Latest News in the pharma Industry

Market News

Merck successfully closes biosimilars transaction

Merck successfully closes biosimilars transaction

1 Sep 2017

Step towards strategic alignment of R&D resources to Healthcare priorities.

Read more 
FDA approves Pfizer's Mylotarg for treatment of AML

FDA approves Pfizer's Mylotarg for treatment of AML

1 Sep 2017

Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive AML.

Read more 
Xeno-free cell culture medium for regenerative medicine research

Xeno-free cell culture medium for regenerative medicine research

31 Aug 2017

StemFit Basic02 offers superior and stable growth performance, high colony forming efficiency and robust scalable cell expansion.

Read more 
Thermo Fisher Scientific completes acquisition of Patheon

Thermo Fisher Scientific completes acquisition of Patheon

31 Aug 2017

Patheon's CDMO capabilities coupled with Thermo's clinical trials services and bioproduction technologies expected to make Thermo and "even stronger partner" for its pharmaceutical and biotech customers.

Read more 
AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

31 Aug 2017

MEDI1341 has the potential to achieve a better efficacy and safety profile than other alpha-synuclein antibodies.

Read more 
Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

30 Aug 2017

Expansion comes as a result of increased industry demand to better understand and characterize APIs and process intermediates at the clinical stage.

Read more 
Novartis receives first ever FDA approval for a CAR-T cell therapy

Novartis receives first ever FDA approval for a CAR-T cell therapy

30 Aug 2017

Kymriah approvaed for children and young adults with B-cell ALL that is refractory or has relapsed at least twice.

Read more 
FDA approves new antibacterial drug

FDA approves new antibacterial drug

30 Aug 2017

First carbapenem-based combination product – combination of meropenem with a new class of beta-lactamase inhibitor.

Read more 
Fire at Ashland facility suspends production of BDO, THF and formaldehyde

Fire at Ashland facility suspends production of BDO, THF and formaldehyde

29 Aug 2017

Volume expected to remain somewhat constrained into the first quarter of fiscal 2018.

Read more 
Acordia's NDA generates Refusal to File letter from FDA

Acordia's NDA generates Refusal to File letter from FDA

29 Aug 2017

FDA cites two manufacturing concerns.

Read more 
Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

28 Aug 2017

Collaboration to focus on a disease target in Parkinson's disease with Berg's Interrogative Biology technology.

Read more 
Sanofi completes the acquisition of Protein Sciences

Sanofi completes the acquisition of Protein Sciences

28 Aug 2017

An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio.

Read more